Pressreleases

Sort by:

Filter by:

09 Dec 2022
Gerresheimer to Expand Significantly in High Value Solutions and Further Accelerates its Sustainable Profitable Growth

By Nat Schaefer

At today’s Capital Markets Day 'Generating Sustainable Value', Gerresheimer, a leading provider of healthcare and beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reaffirmed its growth agenda and increased its revenue and adjusted EBITDA guidance. The company continues to execute consistently its formula g strategy while actively managing global, external challenges.
01 Nov 2022
Join NSF’s Health Sciences Team for World Quality Week and Receive Valuable Resources

By Nat Schaefer

Did you know that 7-11 November is World Quality Week? NSF’s Health Sciences team are proud to be taking part.
01 Nov 2022
Gerresheimer and Stevanato Group Present EZ-fill Smart™, a New and Innovative Ready-To- Fill Vial Platform

By Nat Schaefer

The new EZ-fill Smart™ is an evolution of Stevanato Group’s groundbreaking EZ-fill® platform, and it brings new advancements that can create significant enhancements to customer product offerings amid growing demand for RTU vials.
31 Oct 2022
Gerresheimer and Nelson Labs Announce Strategic Alliance Regarding Extractables and Leachables Lab Testing for the Pharmaceutical and Biotech Industries

By Nat Schaefer

To accelerate and de-risk drug development, Gerresheimer and Nelson Labs announce a formal strategic partnership on analytical and drug compatibility lab testing for the pharmaceutical and biotech industries.
28 Oct 2022
RWS to Showcase Solutions During ISPOR EU

By katiesmithwong

RWS is to take part in ISPOR, which is to take place between 6-9 November in Vienna, Austria.
27 Oct 2022
Gerresheimer and Merck Transform Primary Packaging into Digital Twins

By Nat Schaefer

Gerresheimer, a leading provider of healthcare solutions and drug delivery systems for pharma, biotech and cosmetics and Merck, Darmstadt, a leading science and technology company, jointly developed a digital twin solution to further ensure traceability and trust in crucial steps along the pharmaceutical supply chain.
26 Oct 2022
CPHI Frankfurt: DropControl – Gerresheimer’s Solution for New Ophthalmic Formulations

By Nat Schaefer

With DropControl, Gerresheimer has developed a new dropper insert for modern drugs with low viscosity for ophthalmology, which prevents the drug from flowing out uncontrollably during use.
13 Oct 2022
Novo Nordisk Pharmatech Ranked Among the Top 1% of Companies in EcoVadis Sustainability Assessment Report

By Nat Schaefer

Novo Nordisk Pharmatech announced today that it has been included among the top 1% of companies assessed for the EcoVadis Sustainability Assessment Report. This is the first time that Novo Nordisk Pharmatech is part of the report.
13 Oct 2022
Gerresheimer Reports Double Digit Growth in Revenue and Earnings for the Third Quarter of FY22

By Nat Schaefer

Gerresheimer, a leading provider of healthcare and beauty solutions and drug delivery systems for pharma, biotech and cosmetics, confirms guidance for its financial year 2022 (FY22) after another quarter of strong and profitable growth. Revenue rose organically by 17.4% in the third quarter, reflecting strong customer demand, leading market positions and the ongoing success of its High-Value Solutions. Adjusted EBITDA grew organically by 13.3%.
06 Oct 2022
CPHI Frankfurt 2022: Gx InnoSafe – The Ingenious Solution for Easy-to-Fill Syringes with Passive Needle Protection System

By Nat Schaefer

The Gx InnoSafe safety syringe is the first syringe with an integrated passive safety system. The function of this solution is to prevent accidental injury to an already used syringe by an unintentional needle stick, because the needle is shielded in a sleeve immediately after use.

Drug Discovery

Research & Development

Astellas and AI Proteins sign miniprotein therapeutics deal

Sanofi and ScionxBio partner on mRNA therapies

Clinical Trials

Patient Enrollment

US FDA approves Avacta Group’s IND application for AVA6000

AM-Pharma enrols first patients in Covid-19 phase III trial

Regulation

Drug Filing

Viatris files applications in Japan for approval of Effexor to treat GAD

Scholar Rock submits application of SMA therapy to FDA

Production & Sales

Manufacturing

ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy

Merck introduces single-use reactor to accelerate ADC manufacturing

Packaging & Supply Chain

Packaging

Uwe Röhrhoff Steps Down as Interim CEO of Gerresheimer AG

Gerresheimer at CPHI Frankfurt 2025

Suppliers

No data found

Pressreleases

Gerresheimer to Expand Significantly in High Value Solutions and Further Accelerates its Sustainable Profitable Growth

Join NSF’s Health Sciences Team for World Quality Week and Receive Valuable Resources

Gerresheimer and Stevanato Group Present EZ-fill Smart™, a New and Innovative Ready-To- Fill Vial Platform

Gerresheimer and Nelson Labs Announce Strategic Alliance Regarding Extractables and Leachables Lab Testing for the Pharmaceutical and Biotech Industries

RWS to Showcase Solutions During ISPOR EU

Gerresheimer and Merck Transform Primary Packaging into Digital Twins

CPHI Frankfurt: DropControl – Gerresheimer’s Solution for New Ophthalmic Formulations

Novo Nordisk Pharmatech Ranked Among the Top 1% of Companies in EcoVadis Sustainability Assessment Report

Gerresheimer Reports Double Digit Growth in Revenue and Earnings for the Third Quarter of FY22

CPHI Frankfurt 2022: Gx InnoSafe – The Ingenious Solution for Easy-to-Fill Syringes with Passive Needle Protection System

Pharmaceutical Business review is using cookies

Research & Development

Patient Enrollment

Drug Filing

Manufacturing

Packaging

No data found

Search